Document is current
Any future updates will be listed below
-
Authors
Shankar, Jai
Alcock, Susan
Leeies, Murdoch
Ayroso, Marco
Unrau, Sarah
Park, JaeYeon
Blackwood, Benjamin
Trivedi, Reva
Marin, Roman
Raja, Muhammed
Sinha, Namita
Trivedi, Anurag
Essig, Marco
Martin, Douglas
Grierson, Robert
Zeiler, Frederick A.
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research
- License Information
-
More Information
Article History
Received: 25 December 2024
Accepted: 8 April 2025
First Online: 1 May 2025
Declarations
:
: The study received approval from our institutional ethics board (HS23683; B2020:018) and has been registered on clinicaltrials.gov with the trial registration number of NCT04318665. Deferred consent was approved by the ethics board and was obtained from all patients included in the study.
: FAZ currently has NSERC Alliance Advantage grant (ALLRP-597708-24) support in partnership with Medtronic’s Patient Monitoring Division (ERP-2024-14025) for work that is unrelated to this manuscript. Funding from the partner organization is provided to match NSERC governmental funding only, in keeping with NSERC policies. Medtronic does not direct the research objectives, data collection, analysis, interpretation, or publication of the findings in any way. JS is PI for EMMA Can study funded by Medtronic Canada, unrelated to this manuscript.
